InterAx Biotech received the Seal of Excellence by the European Commission
February 2019, Switzerland-Belgium : InterAx is proud to announce that we received the Seal of Excellence by the European Commission, as the institution managing Horizon 2020, the EU Framework Programme for Research and Innovation 2014-2020 for its Disruptive GPCR Lead Discovery Platform Delivering New and Safer Therapeutics.
